Twice-Weekly Hemodialysis With Adjuvant Pharmacotherapy and Transition to Thrice-Weekly Hemodialysis: A Pilot Study

التفاصيل البيبلوغرافية
العنوان: Twice-Weekly Hemodialysis With Adjuvant Pharmacotherapy and Transition to Thrice-Weekly Hemodialysis: A Pilot Study
المؤلفون: Murea, Mariana, Patel, Ashish, Highland, Benjamin R., Yang, Wesley, Fletcher, Alison J., Kalantar-Zadeh, Kamyar, Dressler, Emily, Russell, Gregory B.
المصدر: American Journal of Kidney Diseases; 20210101, Issue: Preprints
مستخلص: Thrice-weekly hemodialysis (HD) is the most common treatment modality for kidney dysfunction requiring dialysis (KDRD) in the US. We conducted a pilot study to assess the feasibility and safety of incremental-start HD in patients with incident KDRD.
قاعدة البيانات: Supplemental Index
الوصف
تدمد:02726386
15236838
DOI:10.1053/j.ajkd.2021.12.001